BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16540949)

  • 1. Effects of ulinastatin treatment on the cardiopulmonary bypass-induced hemodynamic instability and pulmonary dysfunction.
    Nakanishi K; Takeda S; Sakamoto A; Kitamura A
    Crit Care Med; 2006 May; 34(5):1351-7. PubMed ID: 16540949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation. Effect of ulinastatin on inflammatory response.
    Bingyang J; Jinping L; Mingzheng L; Guyan W; Zhengyi F
    J Cardiovasc Surg (Torino); 2007 Aug; 48(4):497-503. PubMed ID: 17653011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-dose ulinastatin on inflammatory response and pulmonary function in patients with type-A aortic dissection after cardiopulmonary bypass under deep hypothermic circulatory arrest.
    Xu CE; Zou CW; Zhang MY; Guo L
    J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):479-84. PubMed ID: 23545347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass.
    Hiyama A; Takeda J; Kotake Y; Morisaki H; Fukushima K
    J Cardiothorac Vasc Anesth; 1997 Aug; 11(5):580-4. PubMed ID: 9263089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass.
    Sugita T; Watarida S; Katsuyama K; Nakajima Y; Yamamoto R; Mori A
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):437-40. PubMed ID: 12124548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass.
    Schulze CJ; Castro MM; Kandasamy AD; Cena J; Bryden C; Wang SH; Koshal A; Tsuyuki RT; Finegan BA; Schulz R
    Crit Care Med; 2013 Nov; 41(11):2512-20. PubMed ID: 23928836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effects of ulinastatin on the lung injury during cardiopulmonary bypass].
    Wang DJ; Liu JX; Yin BL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):670-2. PubMed ID: 16708806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10.
    Giomarelli P; Scolletta S; Borrelli E; Biagioli B
    Ann Thorac Surg; 2003 Jul; 76(1):117-23. PubMed ID: 12842524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial protective effect of ulinastatin against ischemia/reperfusion injury during open heart surgery with cardiopulmonary bypass].
    Ren TY; Yang XW; Ma Y; Wang F; Qiang WD
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1391-3. PubMed ID: 14521739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of ulinastatin on perioperative inflammatory response to coronary artery bypass grafting with cardiopulmonary bypass].
    Zhou Q; Wang G; Gao C; Chen T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):107-10. PubMed ID: 20197607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of cell adhesion molecules and proinflammatory cytokines during cardiopulmonary bypass and the effect of intervention].
    Li LW; Liu L; He XJ; Zhou JM; Li L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):417-9. PubMed ID: 16190387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury.
    Sato Y; Ishikawa S; Otaki A; Takahashi T; Hasegawa Y; Suzuki M; Yamagishi T; Morishita Y
    Jpn J Thorac Cardiovasc Surg; 2000 Jul; 48(7):428-34. PubMed ID: 10965615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of ulinastatin on cerebral inflammatory response during cardiopulmonary bypass].
    Zou DQ; Zhou JM; Chang YT; He XJ; Yuan GX; Wang DM; Luo HG
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):420-3. PubMed ID: 16190388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of ulinastatin on plasma polymorphonuclear leukocyte elastase activity and respiratory function in patients undergoing cardiopulmonary bypass].
    Mishima A; Takeuti Y; Usami S; Kotani H; Suzuki Y; Yura J
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):607-12. PubMed ID: 2373894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
    Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations.
    Sawa Y; Shimazaki Y; Kadoba K; Masai T; Fukuda H; Ohata T; Taniguchi K; Matsuda H
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):29-35. PubMed ID: 8551786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of urinary trypsin inhibitor on inflammatory cytokines and organ function in patients with cardiopulmonary bypass.
    Xu HY; Rong XS; Wang DP; Jiang SY; Zang ZD; Xia W; Zhang F; Yan J
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2220-2225. PubMed ID: 28537661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery.
    Chen TT; Jiandong-Liu ; Wang G; Jiang SL; Li LB; Gao CQ
    Heart Surg Forum; 2013 Feb; 16(1):E38-47. PubMed ID: 23439357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: effects on TNF-alpha, IL-6, IL-8, IL-10.
    Celik JB; Gormus N; Okesli S; Gormus ZI; Solak H
    Perfusion; 2004 May; 19(3):185-91. PubMed ID: 15298427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.
    Ranasinghe AM; Quinn DW; Pagano D; Edwards N; Faroqui M; Graham TR; Keogh BE; Mascaro J; Riddington DW; Rooney SJ; Townend JN; Wilson IC; Bonser RS
    Circulation; 2006 Jul; 114(1 Suppl):I245-50. PubMed ID: 16820580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.